Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q1 2014 · 10-Q
Revenue$2.63M$2.63M+143.2% vs Q1 2013 Net Income-$118.42K-$118.42KN/M vs Q1 2013 EPS Diluted$0.00$0.00−100.0% vs Q1 2013 Gross Profit$1,610,866+83.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flow-$892,125N/M Free Cash Flowderived-$901,420N/M Margins · derivedGross margin61.2%−19.8 pt vs Q1 2013
Operating margin20.3%−42.7 pt vs Q1 2013
Net margin-4.5%−67.6 pt vs Q1 2013
ended Mar 31, 2014 · filed May 15, 2014 · 45 d after period end